In the fourth part of his Pharma Commerce video interview, Sean O’Hearen, founder and principal consultant at 1st Line ...

The study reveals that resilience varies significantly by race, education, income, and insurance status, highlighting the ...

In the fourth part of this roundtable discussion, a panel of subject matter experts dive into data exchange challenges relating to the Drug Supply Chain Security Act.

In the third part of his Pharma Commerce video interview, Murray Aitken, executive director, IQVIA Institute for Human Data ...

In the first part of his Pharma Commerce video interview, Murray Aitken, executive director, IQVIA Institute for Human Data ...

The agreement grants LEO Pharma exclusive rights to the branded form of spesolimab for generalized pustular psoriasis and ...

The industry veteran will lead the company’s next phase of growth, focusing on faster treatment initiation through integrated ...

In the third part of his Pharma Commerce video interview, Sean O’Hearen, founder and principal consultant at 1st Line Partners, recommends regulatory or verification mechanisms that can help safely ...

Beyond Approval: Why Your Oncology Label Determines Commercial Success A recent Pharmaceutical Executive article explores how in today’s restrictive oncology landscape, securing FDA approval is no ...

Pharmaceutical Commerce connects biopharma executives to insights on business processes, technologies, and strategies for taking approved drugs to market.

In the second part of his Pharma Commerce video interview, Sean O’Hearen, founder and principal consultant at 1st Line Partners, explains how the private sector should strategically support and scale ...

Industry experts react to the developer’s role in preparing for value-based contracting, acknowledging that innovative agreements can support access when evidence is still maturing.